Regeneron Announces Investor Conference Presentations

Rhea-AI Summary

Regeneron Pharmaceuticals (NASDAQ: REGN) has announced its upcoming participation in two major investor conferences. The company will present at the Jefferies London Healthcare Conference on November 19, 2024, at 11:00 a.m. BST (6:00 a.m. ET), and at the Piper Sandler 36th Annual Healthcare Conference on December 5, 2024, at 9:30 a.m. ET.

Both presentations will be accessible via webcast through Regeneron's investor relations website. Recordings and transcripts will remain available for a minimum of 30 days after the events.

News Market Reaction

-0.57%

1 alert

-0.57% News Effect

On the day this news was published, REGN declined 0.57%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

TARRYTOWN, N.Y., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:

• Jefferies London Healthcare Conference at 11:00 a.m. BST (6:00 a.m. ET) on
Tuesday, November 19, 2024

• Piper Sandler 36th Annual Healthcare Conference at 9:30 a.m. ET on Thursday,
December 5, 2024

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company's website for at least 30 days.

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. 

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite^®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center^® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.

For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.

Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com        

FAQ

When is Regeneron (REGN) presenting at the Jefferies London Healthcare Conference 2024?

Regeneron (REGN) is presenting at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 11:00 a.m. BST (6:00 a.m. ET).

What time is Regeneron's (REGN) presentation at the Piper Sandler Healthcare Conference 2024?

Regeneron (REGN) is presenting at the Piper Sandler Healthcare Conference on Thursday, December 5, 2024, at 9:30 a.m. ET.

How long will Regeneron's (REGN) conference webcasts be available for replay?

Regeneron's conference webcasts and transcripts will be archived on the company's website for at least 30 days after the events.

Where can I watch Regeneron's (REGN) investor conference presentations?

The presentations can be accessed through the 'Investors & Media' page on Regeneron's website at investor.regeneron.com/events-and-presentations.